Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Molecular Dissection of the Leukaemia Promoting Properties of the HTLV-1 Tax Oncoprotein


   Division of Cancer Research, Medical Research Institute

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
Dr D W Brighty  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

Human T-cell leukaemia virus (HTLV-1) is the aetiological agent of an aggressive adult T-cell leukaemia/lymphoma (ATLL). The events that promote transformation and immortalisation of CD4+ T cells by HTLV-1 are incompletely understood but the burden of evidence incriminates the viral tax product in this process. Tax is a multifunctional oncoprotein and pleiotropic regulator of viral and cellular gene expression, and a potent inducer of cell proliferation and transformation. Tax-transgenic mice develop thymically derived large-cell lymphomas and leukaemia with clinical, pathological and immunological characteristics typical of ATLL. In this study, we will use lentiviral gene transfer to transduce epitope-tagged Tax into primary haematopoietic progenitor cells. We will examine the effects of Tax and genotoxic stress on haematopoiesis and leukaemogenesis and will use mass-spectrometry and immuno-fluorescence imaging to identify and characterise host-cell proteins that support the Tax-mediated immortalisation of T cells. Understanding the process by which HTLV-1 causes leukaemia will provide new opportunities to develop clinically relevant therapies for ATLL and for chemotherapy-resistant leukaemias in general.


References

Mirsaliotis A, Nurkiyanova K, Lamb D, Kuo CW, and Brighty DW (2007) Resistance to neutralization by antibodies targeting the coiled coil of fusion-active envelope is a common feature of retroviruses. J. Biol. Chem. 282:36724-35.

Mirsaliotis A, Lamb D, Brighty DW. 2008. Nonhelical leash and alpha-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry.
J Virol. 2008 82:4965-73.

Grassmann R, Aboud M, Jeang KT 2005 Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene. 2005 Sep 5;24(39):5976-85.


How good is research at University of Dundee in Clinical Medicine?


Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities